NL-OMON20290招募中不适用
Phenomics & Genomics of Clozapine Pharmacotherapy – New Users
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •he/she is about to initiate CLZ (i.e. he/she has an indication to start CLZ treatment according to the treating physician and he/she is willing to start on CLZ)
- •-he/she has received a diagnosis of schizophrenia, schizophreniform disorder, schizoaffective disorder or psychosis not otherwise specified.
排除标准
- •- admission to a psychiatric unit involuntarily in the context of an ‘inbewaringstelling’ (IBS)
- •- a history of Parkinson’s disease
研究者
相似试验
招募中
不适用
Phenomics & Genomics of Clozapine Pharmacotherapy - Current Userspsychosispsychotic disorders10039628NL-OMON50518niversitair Medisch Centrum Utrecht2,778
撤回
不适用
Phenomics and Genomics of Clozapine Pharmacotherapypsychosispsychotic disorders10039628NL-OMON42072niversitair Medisch Centrum Utrecht4,000
招募中
不适用
Phenomics and Genomics of Clozapine Pharmacotherapy - New Clozapine UsersPsychosispsychotic disorders10039628NL-OMON50475niversitair Medisch Centrum Utrecht200
招募中
不适用
Phenomics & Genomics of Clozapine Pharmacotherapy: To a better understanding of the backgrounds of clozapine useGenetics of clozapine use because of schizophrenia, schizo-affective disorder, schizophreniform disorderNL-OMON20386Dr. J. Luykx2,500
进行中（未招募）
1 期
Biomarkers in patients with Schizophrenia responding to Clozapine treatmentMedDRA version: 21.1 Level: LLT Classification code 10009134 Term: Chronic schizophrenia System Organ Class: 100000004873schizophreniaEUCTR2019-003128-19-DKPsykiatrisk Center Glostrup200